RxDoctor Payments DataLook up a doctor →

Kathryn Shunnarah

Nurse Practitioner · Rockledge, FLNPI 1699837104

Payments from drug & device makers

$22,233in general payments, 2019–2025

Across 920 payments — averaging $24.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$5K
  • Johnson & Johnson$2K
  • AstraZeneca$2K
  • Pfizer$1K
  • Merck$1K
  • Amgen$724
  • plus $10K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis119$4,849
Johnson & Johnson84$1,825
AstraZeneca62$1,534
Pfizer75$1,379
Merck62$1,340
Amgen26$724
Lilly USA, LLC28$695
Incyte Corporation33$683
Astellas Pharma US Inc36$676
Seagen Inc.26$666
Sanofi25$531
Takeda Pharmaceuticals U.S.A., Inc.25$521
Daiichi Sankyo Inc.18$457
Bristol Myers Squibb22$453
Bayer20$368
Eisai Inc.17$353
Regeneron Healthcare Solutions, Inc.13$311
AbbVie14$311
E.r. Squibb & Sons, L.L.C.15$269
Genentech USA, Inc.14$262
Karyopharm Therapeutics Inc.12$241
Puma Biotechnology, Inc.11$206
Beigene USA, Inc.10$200
Ipsen Biopharmaceuticals, Inc9$178
Array Biopharma Inc8$173
GSK7$161
Agios Pharmaceuticals, Inc.7$152
Dendreon Pharmaceuticals LLC4$149
Pharmaessentia USA Corporation6$134
Boehringer Ingelheim5$129
Celltrion USA Inc.1$119
Mirati Therapeutics, Inc.5$116
Servier Pharmaceuticals LLC5$111
Pharmacyclics LLC, An Abbvie Company6$103
Jazz Pharmaceuticals Inc.5$99
Sanofi-aventis U.S. LLC1$98
Deciphera Pharmaceuticals Inc.4$97
Sobi, Inc4$95
Sumitomo Pharma America, Inc.4$92
Beone Medicines USA, Inc.6$89
Myovant Sciences Inc.5$89
AVEO Pharmaceuticals, Inc.4$76
Coherus Oncology, Inc.3$74
Tersera Therapeutics LLC4$69
Geron Corporation3$65
Genmab U.S., Inc.2$63
Pharmacosmos Therapeutics Inc.3$61
Epizyme, Inc.3$51
Exelixis Inc.2$48
ADC Therapeutics America, Inc.3$44
Heron Therapeutics, Inc.2$43
Immunocore Limited2$43
Taiho Oncology, Inc.2$39
EMD Serono, Inc.2$37
Caris MPI, Inc.2$37
Stemline Therapeutics Inc.2$34
Clovis Oncology, Inc.2$33
Novocure Inc.2$30
Recordati_rare_diseases_inc.1$25
Biocon Biologics Inc1$25

How this compares

$22,233 in reported general payments places this provider in the 95th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida →

Medicare billing

Part B allowed, 2024
$12,134
Medicare patients
91
Services billed
1,256

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Rockledge

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →